PHARMAVITE LLC for PHARMAVITE LLC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Food Industry (safety, labeling, etc.) FOO
Support for legal, regulatory pathway for hemp-derived cannabidiol (CBD)
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT New | — |
Budget/Appropriations BUD
Increase funding for the Office of Dietary Supplement Programs within FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Consumer Issues/Safety/Products CSP
H.R.6058-SHOP SAFE act, a bill to provide for contributory liability for certain electronic commerce platforms for use of a counterfeit mark by a third party on such platforms; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Taxation/Internal Revenue Code TAX
S. 12 - Health Savings Act, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Manufacturing MAN
Support for COVID-19 relief packages; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.